Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06109155
PHASE4

The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery

Sponsor: Taichung Veterans General Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to the dose effect of tranexamic acid and the level of ACT on bleeding in adult cardiac surgery. The main questions it aims to answer are: 1. Does higher dose of tranexamic acid reduce the amount of bleeding and blood transfusion? 2. Does lower ACT level during cardiac surgery reduce the amount of bleeding and blood transfusion? Participants will divided into four groups which have different tranexamic acid dose and ACT level during cardiac surgery to see if there is any different in the amount of bleeding and blood transfusion.

Official title: The Dose Effect of Activated Clotting Time and Tranexamic Acid on Bleeding in Adult Cardiac Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-02-08

Completion Date

2026-12-31

Last Updated

2024-02-21

Healthy Volunteers

No

Interventions

DRUG

Tranexamic acid

tranexamic acid will be used in two different doses (50mg/kg vs 20mg/kg). the tranexamic acid pump will start from the begin of anesthesia until all dose is administrated.

Locations (2)

Taichung Veterans General Hospital

Taichung, Taiwan

Taichung Veterans General hospital

Taichung, Taiwan